Rankings
▼
Calendar
CRMD Q1 2025 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$39M
Gross Profit
$37M
95.9% margin
Operating Income
$20M
51.5% margin
Net Income
$21M
52.8% margin
EPS (Diluted)
$0.30
QoQ Revenue Growth
+25.2%
Cash Flow
Operating Cash Flow
$20M
Free Cash Flow
$20M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$150M
Total Liabilities
$35M
Stockholders' Equity
$115M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$39M
$0
—
Gross Profit
$37M
-$818,539
+4679.5%
Operating Income
$20M
-$17M
+220.5%
Net Income
$21M
-$14M
+242.7%
← FY 2025
All Quarters
Q2 2025 →